Advisors Asset Management Inc. Has $832,000 Stock Holdings in Becton, Dickinson and Company (NYSE:BDX)

Advisors Asset Management Inc. lowered its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 5.8% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,452 shares of the medical instruments supplier’s stock after selling 211 shares during the period. Advisors Asset Management Inc.’s holdings in Becton, Dickinson and Company were worth $832,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of BDX. Livelsberger Financial Advisory acquired a new stake in shares of Becton, Dickinson and Company in the 3rd quarter valued at approximately $26,000. Ashton Thomas Securities LLC bought a new position in Becton, Dickinson and Company in the 3rd quarter valued at approximately $33,000. Tompkins Financial Corp boosted its position in Becton, Dickinson and Company by 44.2% in the third quarter. Tompkins Financial Corp now owns 150 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 46 shares in the last quarter. Sound Income Strategies LLC grew its stake in shares of Becton, Dickinson and Company by 35.8% during the third quarter. Sound Income Strategies LLC now owns 167 shares of the medical instruments supplier’s stock worth $40,000 after buying an additional 44 shares during the last quarter. Finally, Opal Wealth Advisors LLC acquired a new position in shares of Becton, Dickinson and Company during the second quarter worth $45,000. 86.97% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Raymond James lowered their target price on Becton, Dickinson and Company from $275.00 to $270.00 and set an “outperform” rating for the company in a report on Friday, August 2nd. Citigroup upgraded shares of Becton, Dickinson and Company from a “neutral” rating to a “buy” rating and raised their price objective for the company from $255.00 to $275.00 in a report on Tuesday, October 1st. Evercore ISI boosted their target price on shares of Becton, Dickinson and Company from $286.00 to $290.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Finally, StockNews.com upgraded shares of Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a report on Thursday, August 8th. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $283.00.

Becton, Dickinson and Company Trading Down 0.6 %

NYSE:BDX opened at $224.20 on Wednesday. Becton, Dickinson and Company has a 52 week low of $218.75 and a 52 week high of $249.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.74 and a current ratio of 1.17. The firm’s fifty day moving average is $234.83 and its 200-day moving average is $234.40. The firm has a market cap of $64.80 billion, a P/E ratio of 37.74, a P/E/G ratio of 1.67 and a beta of 0.43.

Becton, Dickinson and Company (NYSE:BDX) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $3.81 earnings per share for the quarter, topping analysts’ consensus estimates of $3.77 by $0.04. The firm had revenue of $5.44 billion during the quarter, compared to the consensus estimate of $5.38 billion. Becton, Dickinson and Company had a return on equity of 14.89% and a net margin of 8.55%. The business’s revenue was up 6.9% compared to the same quarter last year. During the same period last year, the business posted $3.42 EPS. Equities analysts expect that Becton, Dickinson and Company will post 14.43 earnings per share for the current year.

Becton, Dickinson and Company Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 9th will be given a dividend of $1.04 per share. This is an increase from Becton, Dickinson and Company’s previous quarterly dividend of $0.95. The ex-dividend date is Monday, December 9th. This represents a $4.16 annualized dividend and a dividend yield of 1.86%. Becton, Dickinson and Company’s dividend payout ratio (DPR) is 70.03%.

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.